OM:CAMXPharmaceuticals
Assessing Camurus (OM:CAMX) Valuation After Softer Q1 2026 Earnings And Recent Share Price Weakness
Camurus (OM:CAMX) reported first quarter 2026 results with sales of SEK 533.1 million and net income of SEK 143.82 million, both lower than the prior year, a backdrop investors are now reassessing.
See our latest analysis for Camurus.
The earnings miss appears to have fed into recent trading, with the share price down 12.26% over the past 30 days and 16.99% year to date, while the 5 year total shareholder return of 146.60% still points to a strong longer term journey.
If this kind of...